Edition:
United Kingdom

GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,490.80GBp
22 Jan 2019
Change (% chg)

-- (--)
Prev Close
1,490.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
8,509,403
52-wk High
1,648.80
52-wk Low
1,235.20

Select another date:

Mon, Jan 21 2019

Photo

GSK Chairman Hampton to step down ahead of split

GlaxoSmithKline Plc Chairman Philip Hampton will step down after more than three and a half years in the role, as Britain's biggest drugmaker prepares to split its business into two.

GSK Chairman Hampton to step down ahead of split

GlaxoSmithKline Plc Chairman Philip Hampton will step down after more than three and a half years in the role, as Britain's biggest drugmaker prepares to split its business into two.

UPDATE 2-GSK Chairman Hampton to step down ahead of split

* GSK says started search for a successor (Adds details on Hampton, background)

GSK Chairman Hampton to step down

Jan 21 GlaxoSmithKline plc Chairman Philip Hampton will step down after more than three and a half years in the role, the drugmaker announced on Monday.

GlaxoSmithKline to look for early-stage assets - CEO

GlaxoSmithKline Plc will actively look to buy early-stage assets and partner with companies, the drugmaker's chief executive officer said on Tuesday.

GlaxoSmithKline to look for early-stage assets: CEO

GlaxoSmithKline Plc will actively look to buy early-stage assets and partner with companies, the drugmaker's chief executive officer said on Tuesday.

UPDATE 1-GlaxoSmithKline to look for early-stage assets - CEO

Jan 8 GlaxoSmithKline Plc will actively look to buy early-stage assets and partner with companies, the drugmaker's chief executive officer said on Tuesday.

GlaxoSmithKline to look for early-stage assets - CEO

Jan 8 GlaxoSmithKline Plc will actively look to buy early-stage assets and partner with companies, the British drugmaker's chief executive officer said on Tuesday.

Drugmaker GSK to split after striking Pfizer consumer health deal

LONDON GlaxoSmithKline plans to split into two businesses -- one for prescription drugs and vaccines, the other for over-the-counter products -- after forming a new joint venture with Pfizer's consumer health division. | Video

Drugmaker GSK to split after striking Pfizer consumer health deal

LONDON GlaxoSmithKline plans to split into two businesses -- one for prescription drugs and vaccines, the other for over-the-counter products -- after forming a new joint venture with Pfizer's consumer health division. | Video

Select another date: